J&J’s Bankruptcy Effort Fails Supreme Court Test, Holdouts Say
WEB13 hours ago · Save. Johnson & Johnson’s third effort to end lawsuits claiming its baby powder caused thousands of women to get cancer should be dismissed because it violates US Supreme Court precedent and ...
Top Three Questions on Johnson & Johnson’s Third Talc Bankruptcy
WEB1 day ago · J&J’s latest chapter 11 filing to end its mass talc lawsuits faces questions on multiple fronts. Johnson & Johnson proposes to pay $10 billion in compensation over 25 years in exchange for a ...
Johnson & Johnson to pay $6.5 billion to resolve nearly all ... - NBC News
WEBMay 1, 2024 · Justin Sullivan / Getty Images file. Johnson & Johnson on Wednesday said it plans to pay $6.5 billion over 25 years to settle nearly all of the thousands of lawsuits in the U.S. claiming its talc ...
J&J to pump another $13B into its MedTech ... - Associated Press News
WEBApr 5, 2024 · Johnson & Johnson is pumping more money into heart care with a roughly $13 billion deal for Shockwave Medical, which specializes in technology that helps open clogged arteries.
J&J to acquire Ambrx Biopharma, a cancer drug developer, for $2B
WEBJan 8, 2024 · The deal, which was announced on the first day of the annual JPMorgan Healthcare Conference, makes J&J the latest drugmaker to bet on antibody-drug conjugates, or ADCs. The acquisition also...
Press Releases - Johnson & Johnson
WEBSep 16, 2024 · Explore all Johnson & Johnson published press releases by date and/or topic of news.
Johnson & Johnson Will Break Itself Up Into Two Companies
WEBNov 12, 2021 · Johnson & Johnson will keep its more profitable, faster-growing businesses in pharmaceuticals and medical devices. The planned breakup comes after years of tribulations for Johnson & Johnson.
Johnson & Johnson Announces Data to Support Boosting its …
WEBNEW BRUNSWICK, N.J., August 25, 2021 – Johnson & Johnson today announced data supporting the use of its COVID-19 vaccine as a booster shot for people previously vaccinated with the single-shot Johnson & Johnson vaccine.
Johnson & Johnson Announces Real-World Evidence and Phase 3 …
WEBSep 21, 2021 · Innovative Medicine. Johnson & Johnson Announces Real-World Evidence and Phase 3 Data Confirming Strong and Long-Lasting Protection of Single-Shot COVID-19 Vaccine in the U.S. Additional data show a booster increases protection. 94 percent protection in the U.S. with booster given at two months.
Extra Shots from J. & J. and Pfizer Give Immune Boost, Companies …
WEBAug 25, 2021 · The Johnson & Johnson one-shot vaccine was absent from the government’s booster plan announced last week. But with the new data, the company hopes to be part of the initial distribution of...